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Background: The aim of the present three-arm parallel trial was to compare the effectiveness of chewing gum and ibuprofen in 
the control of orthodontic pain.
Methods: Patients to undergo orthodontic treatment at a private orthodontic clinic were randomly divided into three parallel 
groups, each of which took either a placebo, ibuprofen or chewing gum. The eligibility criteria included patients in the full 
permanent dentition with moderate crowding requiring the extraction of two mandibular and two maxillary premolars. The main 
outcome was the patient's level of discomfort, which was assessed by a 0–10 numeric rating scale (NRS) at two hours, six hours, 
at bedtime, 24 hours, two days, three days and seven days after the placement of initial arch wires in four functions including 
chewing, biting, occluding back teeth, and occluding front teeth. Randomisation was accomplished according to the patient's 
clinic entrance number and by using a table of random numbers. The patients in the placebo and ibuprofen groups were blinded 
to the type of medication used. The differences in the groups were analysed using repeated measures ANOVA.
Results: Sixty-six patients between 12 and 30 years were randomised in a 1:1:1 ratio. The pain questionnaire response rate was 
100% in the three groups, but six patients were excluded and consequently 60 patients were analysed (N = 20 in each group). 
There was no significant difference between the chewing gum and ibuprofen groups during any oral function at any time point (p 
> 0.05). However, repeated measures ANOVA showed that patients in the placebo group experienced significantly higher pain 
scores compared with patients in the ibuprofen and chewing gum groups at two hours, six hours, at bedtime, at 24 hours and 
two days after initial arch wire placement (p < 0.05). No patient harm was observed in this study. 
Conclusions: In contrast to the common orthodontic belief that gum chewing may lead to bracket breakage, it seems that 
chewing gum is as beneficial as medication for pain relief and can be a recommended alternative during orthodontic treatment.
(Aust Orthod J 2020; 36:  38-44)
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Introduction
Pain from appliances is common during orthodontic 
treatment, and the fear of pain is a key reason why 
patients may avoid seeking care.1 Approximately 90 
to 95% of patients report some level of discomfort 
during appliance treatment.2-4 Pressure applied to a 
tooth by orthodontic forces results in an inflammatory 
response within the periodontal ligament (PDL), 
which subsequently stimulates the release of mediators 
and generates pain and discomfort.5,6 Pain is usually 
felt within a few hours following force application and 
reaches a maximum intensity at 24 hours, after which 
the pain gradually subsides and disappears after five to 
seven days.1,4,7-10
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Various methods have been suggested to control pain 
throughout appliance treatment. The use of non-
steroidal anti-inflammatory drugs (NSAIDs), such 
as ibuprofen that disrupts prostaglandin metabolism, 
is the most common method of pain management.11 
However, the potential side effects of NSAIDs, such 
as gastrointestinal disorders, and the inhibition of 
prostaglandin synthesis that also decreases the rate 
of tooth movement are concerning, particularly in 
young patients.12-14
Because of the concerns, non-medication methods 
of pain control, such as low-level laser therapy,15,16 
transcutaneous electrical nerve stimulation17,18 and 
chewing gum or chewing on a bite wafer have been 
advocated.16,19 The mechanism of action of these 
methods is to loosen the tightly grouped fibres around 
the nerves and blood vessels in the PDL and to restore 
normal vascular and lymphatic circulation. This 
results in the prevention or resolution of inflammation 
and oedema and subsequently heralds a reduction in 
pain and discomfort.19-22 However, the effectiveness of 
chewing gum and its protocol for use in the relief of 
orthodontic pain have not been widely investigated 
compared with other methods, likely because of the 
fear that chewing gum may increase the incidence 
of bracket breakage. The present study was therefore 
designed to assess the efficacy of chewing gum to 
control orthodontic pain compared with ibuprofen 
and a placebo to establish a management guideline.
Methods
The present study was approved by the Ethics 
Committee of the Kerman University of Medical 
Sciences (No. KA/92/477) and conducted in a private 
orthodontic clinic. Informed consent was obtained 
from all patients who participated in this study.
The inclusion criteria identified:
a.  Patients in the full permanent dentition.
b.  Patients requiring full upper and lower fixed 
orthodontic treatment with no additional 
appliance (i.e., trans-palatal arch, headgear or 
elastics).
c.  Patients with no active periodontal disease or 
history of previous orthodontic treatment.
d.  Patients with no medical or mental problems.
e.  Patients with moderate crowding (4–8 mm) in 
both arches.
f.  Patients requiring the extraction of two maxillary 
and two mandibular premolars for orthodontic 
purposes.
Sixty-six patients between 12 and 30 years of age 
participated in the study. The subjects were randomly 
divided into three parallel groups in a 1:1:1 ratio 
according to their clinic admission number and by 
using a table of random numbers. Tooth extraction was 
performed at least two weeks prior to the placement 
of orthodontic appliances. Orthodontic separating 
elastics were placed one week prior to banding. All 
patients received bands on their first molars, 0.022 
× 0.028 inch MBT brackets (Ortho Organizers, 
USA) and 0.014 inch NiTi initial arch wires (G&H, 
USA) in one appointment. The method of ligation 
was standardised by the complete engagement of the 
arch wires on all teeth using elastomeric ligatures. 
Patients in the placebo group received vitamin B6 
(40 mg; DarouPakhsh Co., Tehran, Iran) for pain 
relief. Patients in the ibuprofen group received 
ibuprofen (400mg; DarouPakhsh Co., Tehran, Iran). 
The patients in these two groups were blinded to the 
type of ingested drug and were asked to take a tablet 
immediately after arch wire placement and at eight-
hourly intervals for one week if the pain persisted. 
Patients in the third group chewed sugar-free gum 
(Trident, TX, USA) for 10 minutes immediately after 
arch wire placement and at eight-hourly intervals for 
one week if the pain continued.
The patientʼs level of discomfort was assessed using 
a 0–10 numeric rating scale (NRS) at two hours, six 
hours, at bedtime after arch wire placement and at 24 
hours, two days, three days, and seven days after the 
first appointment. The NRS used 0–10 integers to 
indicate the level of pain on a horizontal, 10 cm line 
comprising two endpoints; 0 indicated no pain while 
10 indicated unbearable pain. All patients received 
an NRS questionnaire in the form of a seven-page 
booklet for noting the seven recording times. Each 
page contained four 10 cm NRSs for each function 
and patients were given oral instructions on how to 
complete the NRS questionnaire. The patients were 
asked to determine the level of pain experienced at 
the appropriate time points by marking the integers 
on the scale line. The severity of pain was expressed 
and experienced during four oral functions including 
chewing, biting, occluding the posterior teeth, and 
occluding the anterior teeth. To determine the biting 
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and chewing effects, patients were asked to bite 
or chew on a slice of apple20 and score the level of 
pain experienced. For occluding of the anterior and 
posterior teeth, the patients were asked to bite the 
front teeth edge-to-edge with a light force, to secondly 
occlude the posterior teeth with a light force, and then 
to record the level of pain experienced. The patients 
were instructed not to take any other analgesic 
medications in addition to those being used during 
the trial until the questionnaire was completed. 
The normal distribution of variables was confirmed 
by the Kolmogorov-Smirnov test. The differences 
between the groups relevant to pain scores were 
analysed by repeated measures ANOVA and Tukey’s 
test. SPSS software (version 19; SPSS, II., USA) was 
used for statistical analysis, and the level of significance 
for all tests was set at p < 0.05. 
Results
Sixty-six patients between 12 and 30 years of age 
were randomised in 1:1:1 ratio to either the placebo, 
ibuprofen or the chewing gum group. No patient 
was lost to follow-up, but three patients took 
additional analgesics and three patients filled out the 
questionnaire incompletely (Figure 1). The study 










































Figure 1. CONSORT diagram showing the flow of participants through each stage of the trial.
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Table I shows the demographic characteristics of the 
patients and indicates that the three groups were not 
significantly different in age and gender characteristics 
(p > 0.05).
The pain questionnaire response rate was 100% in 
the three groups, but six patients were excluded from 
the analysis because of additional analgesic intake or 
an incomplete questionnaire. Consequently, only 60 
patients were analysed (N = 20 in each group). Table II 
shows the mean pain score for the different functions 
at the various time points in the three groups. The 
pattern of pain reported over time was almost similar 
for the three groups as pain reached its maximum 
intensity at 24 hours after arch wire placement (Table 
II). The differences in pain scores are presented 
individually for each function.
Differences in pain scores on ‘chewing’
The result of ANOVA demonstrated that patients in 
the placebo group experienced significantly higher 
pain scores compared with patients in the ibuprofen 
and chewing gum groups at two hours, six hours, at 
bedtime, 24 hours and two days after initial arch wire 
placement (p < 0.05) (Table II). The maximum pain 
experienced was reported in the placebo group at 24 
hours (mean: 6.70; 95% CI: 5.2 to 7.3) after initial 
arch wire placement; minimum pain pertained to 
the ibuprofen group at two hours (mean: 1.55; 95% 
CI: 0.4 to 2.7) after initial arch wire placement. No 
statistically significant difference was found between 
the ibuprofen and chewing gum groups at any time 
point (p > 0.05).
Differences in pain scores on ‘biting’
With respect to pain experienced on biting, patients 
in the ibuprofen and chewing gum groups showed 
significantly less pain than the placebo group at two 
hours, six hours, bedtime and 24 hours after initial 
arch wire placement (p <  0.05) (Table II). However, 
the chewing gum group did not show any significant 
difference in pain score compared with the ibuprofen 
group at any time point (p > 0.05). Maximum pain 
was experienced by the placebo group (mean: 7.65; 
95% CI: 6.5 to 8.7) at 24 hours after initial arch wire 
placement while minimum pain pertained to the 
ibuprofen group at two hours (mean: 2.55; 95% CI: 
1.22 to 3.88) after initial arch wire placement. 
Differences in pain scores on ‘occluding the 
front teeth’
The ANOVA differences in pain experienced on 
occluding the anterior teeth demonstrated that 
patients in the placebo group had significantly 
higher pain scores than patients in the ibuprofen 
and chewing gum groups at bedtime and at 24 hours 
after initial arch wire placement (p < 0.05) (Table II). 
However, the difference between the ibuprofen and 
chewing gum groups was not significant at any time 
point (p > 0.05). The maximum pain experienced was 
related to the placebo group at 24 hours (mean: 7.60; 
95% CI: 6.4 to 8.7) after initial arch wire placement. 
Minimum pain pertained to the placebo group on day 
seven (mean: 3.10; 95% CI: 2.07 to 4.13) after initial 
arch wire placement.
Differences in pain scores on ‘occluding the 
back teeth’
The ANOVA demonstrated that patients in the 
placebo group experienced significantly higher pain 
occluding the posterior teeth at bedtime and at 24 
hours after initial arch wire placement (p < 0.05) (Table 
II). However, no statistically significant differences 
were found between the ibuprofen and chewing gum 
groups at any time point (p > 0.05). The maximum 
pain was again related to the placebo group at 24 
hours (mean: 6.25; 95% CI: 5.01 to 7.49) after initial 
arch wire placement; minimum pain pertained to the 
chewing gum group on day seven (mean: 1.50; 95% 
CI: 0.15 to 2.85) after initial arch wire placement.
Placebo=20 Ibuprofen=20 Chewing gum=20 P value*
Gender: male/female 6/14 4/16 5/15 0.645
Age, y: mean (SD) 18.90 (2.4) 20.25 (4.45) 19.80 (4.43) 0.875
Table I.  Baseline characteristics of patients in each treatment group.
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Discussion 
The present study compared the efficacy of chewing 
gum, ibuprofen and a placebo for pain relief after 
initial arch wire placement.
The intensity of pain experienced on performing four 
oral functions increased two hours after initial arch 
wire placement and reached maximum intensity at 
24 hours. This result is in accordance with previous 
studies.7,11,20,23
The present results showed that the intensity of 
pain in the placebo group was significantly higher 
than that experienced in the ibuprofen and chewing 
gum groups at two hours, six hours, bedtime, 24 
hours and two days after initial arch wire placement. 
However, no significant difference was found between 
the ibuprofen and chewing gum groups for any oral 
function at any time point (p > 0.05).
Proffit and Fields suggested non-medication methods 
such as chewing gum for orthodontic pain control 
during orthodontic treatment.19 However, the effec-
tiveness of chewing gum has not been widely investi-
gated, probably because of the fear that chewing gum 
increases the likelihood of bracket breakage. In the 
present study, there was no clinically nor statistically 
significant difference in the frequency of appliance 
breakage between the ibuprofen and chewing gum 
groups (three and four brackets, respectively). This re-
sult confirms previous studies24,25 in which there was 
no evidence that chewing gum increased the level of 
appliance damage.
Farzanegan et al.20 reported that most people chew 
gum using their posterior teeth, which reduced pain 
in those teeth more effectively compared with the 
anterior teeth. Chewing gum was therefore prescribed 
for five minutes and at eight-hourly intervals, which 
























































































































































































P value 0.199 0.076 0.004* 0.001* 0.068 0.125 0.695
Table II.  Descriptive statics for the three groups and repeated measures ANOVA results.
NRS pain scores; mean (95% CI)
*Mean difference was significant at the 0.05 level.
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varied from the present study, in which chewing gum 
was prescribed for 10 minutes. Pain significantly 
reduced in both the anterior and posterior teeth.
Hamid et al.26 compared the efficacy of ibuprofen and 
chewing gum for orthodontic pain relief. Chewing 
gum was also prescribed for five minutes at eight-hourly 
intervals, which produced a reduction in pain score 
compared with ibuprofen analgesia. In the present 
study, chewing gum was as effective as ibuprofen intake. 
The variation may be explained by the difference in 
appliance application as only the maxillary arch was 
bonded and no other pain functions were investigated.
Recently Ireland et al.,24 in a multicentre, randomised 
clinical trial, compared the efficacy of sugar-free 
chewing gum against ibuprofen for orthodontic pain 
relief. It was reported that patients who chewed gum 
used less ibuprofen compared with an ibuprofen-
only group. Furthermore, there was no clinically or 
statistically significant difference in appliance breakage 
between the chewing gum and ibuprofen groups. 
However, the major differences between that study 
and the current one were no stipulation as to the types 
of fixed appliance, duration of gum chewing, aligning 
wires, ligation method, malocclusion and amount of 
crowding.
In addition to the local effect of gum chewing on the 
structure of the PDL, it seems that chewing gum has 
proven effects on nociceptive transmission. Mohri et 
al.27 explained that rhythmic gum chewing suppresses 
nociceptive transmission via the 5-HT (serotonergic 
neurons) descending inhibitory pathway, which in 
turn, decreases pain scores. Kamiya et al.28 reported 
that chewing gum for 20 minutes activated the ventral 
part of the prefrontal cortex and evoked augmented 
activity of 5-HT neurons in the dorsal raphe nucleus 
and therefore suppressed nociceptive responses. The 
study by Kamiya et al. focused on oxygenation changes 
in the prefrontal cortex and concluded that the 
analgesic effects of chewing gum were associated with 
a significant increase in 5-HT level in whole blood.
Based on previous studies, it appears that chewing 
gum has both local and central effects on pain relief. 
Therefore, reducing pain in the anterior teeth in 
the present study was likely due to a central effect. 
It should be noted that the duration of chewing is 
perhaps important as the present study arbitrarily 
chose 10 minutes but, according to Kamiya et al,28 
chewing gum for longer durations may have a greater 
effect on pain relief.
An additional factor that should be considered from 
the present study is the placebo analgesic effect. A 
placebo effect is mediated by the release of endogenous 
neuromodulators in the brain, including opioids, 
cholecystokinin, and dopamine.29-32 Recent studies 
have shown that the range of placebo response varies 
considerably between individuals, from no effect (‘non-
responder’) to complete pain relief. Previous studies 
support the hypothesis that neuropsychological, 
genetic, and brain-related variables might predict 
the capacity of placebo analgesic responses in healthy 
subjects.33-35 Therefore, the placebo effect may have a 
role in reducing pain in the chewing gum groups, but 
its exact effect is not clear. Further research is needed 
to determine the individual markers of placebo 
responsiveness, which may help to stratify patients in 
clinical trials. 
Because of the nature of the present study, blinding of 
the chewing gum group was not feasible. Accordingly, 
gum was chewed for only 10 minutes and further 
research is recommended to determine the impact of 
chewing gum and find the optimal chewing duration 
needed to reduce orthodontic pain.
Although the blinding of patients in the chewing gum 
group was not possible at the intervention stage, the 
outcome assessment was blinded, and therefore the 
risk of bias may be considered low. The limitation 
of the present study might be the uncertainty of the 
contribution of the placebo effect in reducing pain. 
The experience of pain is highly subjective and its 
precise evaluation is difficult.
To summarise, the present results may be limited 
because the current research was undertaken in a 
single centre by one clinician. However, chewing gum 
is simple, inexpensive, has no side effects and was 
accepted by all patients without concern.
Conclusions
In contrast to the common belief by orthodontists that 
chewing gum during fixed orthodontic treatment may 
lead to appliance breakage, it appears that chewing 
gum can reduce pain after orthodontic appliance 
activation as efficiently as ibuprofen and therefore 
may be a cost effective substitute for drug medication 
during orthodontic treatment with low risk and high 
acceptance.
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